Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2028-01-07 (411 days left) |
| Published | 2024-10-28 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-25-024. CFDA: 93.853, 93.866
The buyer, the value, the full description and the link to the official notice are available with a free account.